Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Biohaven Pharmaceutical Holding Debt to Equity Ratio 2016-2018 | BHVN

Current and historical debt to equity ratio values for Biohaven Pharmaceutical Holding (BHVN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Biohaven Pharmaceutical Holding debt/equity for the three months ending September 30, 2018 was 0.00.
Biohaven Pharmaceutical Holding Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.07B 0.00
2018-06-30 $0.00B $0.12B 0.00
2018-03-31 $0.00B $0.11B 0.00
2017-12-31 $0.00B $0.13B 0.00
2017-09-30 $0.00B $0.16B 0.00
2017-06-30 $0.00B $0.19B 0.00
2017-03-31 $0.00B $-0.05B -0.01
2016-12-31 $0.00B $-0.05B -0.01
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.00
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.446B $0.000B
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.706B 14.55
Gilead Sciences (GILD) United States $88.678B 10.68
Biogen (BIIB) United States $68.295B 13.83
Celgene (CELG) United States $60.136B 11.67
Vertex Pharmaceuticals (VRTX) United States $49.548B 86.55
Illumina (ILMN) United States $44.632B 51.99
Regeneron Pharmaceuticals (REGN) United States $43.798B 22.19
Alexion Pharmaceuticals (ALXN) United States $25.498B 17.45
BioMarin Pharmaceutical (BMRN) United States $17.033B 0.00
Incyte (INCY) United States $16.456B 454.88
Seattle Genetics (SGEN) United States $11.330B 0.00
Exact Sciences (EXAS) United States $9.349B 0.00
QIAGEN (QGEN) Netherlands $8.374B 26.78
Alnylam Pharmaceuticals (ALNY) United States $8.161B 0.00
BeiGene (BGNE) Cayman Islands $8.097B 0.00
Sarepta Therapeutics (SRPT) United States $8.038B 0.00
Bluebird Bio (BLUE) United States $6.842B 0.00
Exelixis (EXEL) United States $6.611B 18.74
Bio-Techne Corp (TECH) United States $6.081B 41.07
Amarin (AMRN) Ireland $5.657B 0.00
Galapagos (GLPG) Belgium $5.312B 0.00
Alkermes (ALKS) Ireland $5.135B 3305.00
Moderna (MRNA) United States $5.118B 0.00
Horizon Pharma Public (HZNP) Ireland $3.674B 15.12
MorphoSys AG Unsponsored ADR (MOR) Germany $3.674B 0.00
Array BioPharma (ARRY) United States $3.626B 0.00
Guardant Health (GH) United States $3.482B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.429B 0.00
Allogene Therapeutics (ALLO) United States $3.375B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.290B 0.00
Emergent Biosolutions (EBS) United States $3.099B 26.11
Ascendis Pharma (ASND) Denmark $3.096B 0.00
Blueprint Medicines (BPMC) United States $2.926B 0.00
China Biologic Products (CBPO) China $2.665B 18.97
Akcea Therapeutics (AKCA) United States $2.617B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.587B 0.00
Genomic Health (GHDX) United States $2.565B 86.58
ACADIA Pharmaceuticals (ACAD) United States $2.542B 0.00
Immunomedics (IMMU) United States $2.525B 0.00
Global Blood Therapeutics (GBT) United States $2.498B 0.00
Repligen (RGEN) United States $2.419B 75.55
Ligand Pharmaceuticals (LGND) United States $2.400B 18.36
Halozyme Therapeutics (HALO) United States $2.300B 51.32
Reata Pharmaceuticals (RETA) United States $2.230B 0.00
Amicus Therapeutics (FOLD) United States $2.217B 0.00
Arena Pharmaceuticals (ARNA) United States $2.176B 0.00
Myriad Genetics (MYGN) United States $2.160B 21.40
Mirati Therapeutics (MRTX) United States $2.080B 0.00
Denali Therapeutics (DNLI) United States $2.059B 0.00
Innoviva (INVA) United States $1.973B 11.16
AnaptysBio (ANAB) United States $1.900B 0.00
Acceleron Pharma (XLRN) United States $1.877B 0.00
Insmed (INSM) United States $1.791B 0.00
MyoKardia (MYOK) United States $1.788B 0.00
Allakos (ALLK) United States $1.733B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.717B 0.00
Spark Therapeutics (ONCE) United States $1.635B 0.00
Atara Biotherapeutics (ATRA) United States $1.618B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.575B 125.13
REGENXBIO (RGNX) United States $1.570B 21.06
Zai Lab Unsponsored ADR (ZLAB) China $1.493B 0.00
NeoGenomics (NEO) United States $1.473B 121.23
Medicines (MDCO) United States $1.456B 0.00
Cambrex (CBM) United States $1.435B 10.72
Aimmune Therapeutics (AIMT) United States $1.289B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.279B 0.00
Myovant Sciences (MYOV) United Kingdom $1.232B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.219B 0.00
WAVE Life Sciences (WVE) Singapore $1.202B 0.00
Clovis Oncology (CLVS) United States $1.194B 0.00
UniQure (QURE) Netherlands $1.161B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.147B 0.00
Rubius Therapeutics (RUBY) United States $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.130B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.111B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.084B 0.00
Lion Biotechnologies (IOVA) United States $1.081B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.031B 0.00
Audentes Therapeutics (BOLD) United States $1.023B 0.00
Editas Medicine (EDIT) United States $1.002B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.993B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Solid Biosciences (SLDB) United States $0.907B 0.00
Puma Biotechnology (PBYI) United States $0.903B 0.00
Retrophin (RTRX) United States $0.892B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.865B 0.00
InflaRx (IFRX) Germany $0.820B 0.00
Coherus BioSciences (CHRS) United States $0.796B 0.00
Athenex (ATNX) United States $0.775B 0.00
Novavax (NVAX) United States $0.773B 0.00
Principia Biopharma (PRNB) United States $0.767B 0.00
Acorda Therapeutics (ACOR) United States $0.758B 9.60
Apellis Pharmaceuticals (APLS) United States $0.756B 0.00
Vericel (VCEL) United States $0.750B 0.00
Heska (HSKA) United States $0.739B 60.49
UROGEN PHARMA (URGN) Israel $0.738B 0.00
Dynavax Technologies (DVAX) United States $0.730B 0.00
G1 THERAPEUTICS (GTHX) United States $0.728B 0.00
CytomX Therapeutics (CTMX) United States $0.725B 0.00
Epizyme (EPZM) United States $0.724B 0.00
AC Immune SA (ACIU) Switzerland $0.713B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.706B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.686B 0.00
Cellectis (CLLS) France $0.661B 0.00
Intra-Cellular Therapies (ITCI) United States $0.657B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.652B 0.00
Revance Therapeutics (RVNC) United States $0.647B 0.00
ANI Pharmaceuticals (ANIP) United States $0.627B 11.99
RA PHARMCTL INC (RARX) United States $0.627B 0.00
Intellia Therapeutics (NTLA) United States $0.615B 0.00
Twist Bioscience (TWST) United States $0.610B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.609B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.604B 0.00
Cara Therapeutics (CARA) United States $0.603B 0.00
Kura Oncology (KURA) United States $0.588B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.586B 0.00
Viking Therapeutics (VKTX) United States $0.580B 0.00
Arvinas (ARVN) United States $0.531B 0.00
UNITY Biotechnology (UBX) $0.515B 0.00
Anika Therapeutics (ANIK) United States $0.506B 20.93
Zymeworks (ZYME) Canada $0.505B 0.00
ObsEva SA (OBSV) Switzerland $0.486B 0.00
Osiris Therapeutics (OSIR) United States $0.483B 0.00
Inovio Pharmaceuticals (INO) United States $0.477B 0.00
Eidos Therapeutics (EIDX) United States $0.467B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.465B 0.00
Prothena (PRTA) Ireland $0.462B 0.00
Zealand Pharma (ZEAL) Denmark $0.454B 5.01
PDL BioPharma (PDLI) United States $0.445B 7.26
Mesoblast (MESO) Australia $0.442B 0.00
Arcus Biosciences (RCUS) United States $0.428B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.428B 0.00
Agenus (AGEN) United States $0.427B 0.00
Gritstone Oncology (GRTS) United States $0.423B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.423B 0.00
Synthorx (THOR) United States $0.411B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.403B 0.00
BeyondSpring (BYSI) United States $0.395B 0.00
DBV Technologies (DBVT) France $0.391B 0.00
Five Prime Therapeutics (FPRX) United States $0.388B 0.00
MediciNova (MNOV) United States $0.382B 0.00
Kezar Life Sciences (KZR) United States $0.379B 0.00
Senesco Technologies (ELOX) United States $0.373B 0.00
Scholar Rock Holding (SRRK) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Cytokineticsorporated (CYTK) United States $0.367B 0.00
Cellular Biomedicine (CBMG) United States $0.344B 0.00
Kindred Biosciences (KIN) United States $0.343B 0.00
Stemline Therapeutics (STML) United States $0.337B 0.00
Replimune (REPL) United States $0.334B 0.00
Abeona Therapeutics (ABEO) United States $0.330B 0.00
AVROBIO (AVRO) United States $0.323B 0.00
Krystal Biotech (KRYS) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.307B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.302B 0.00
Kodiak Sciences (KOD) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Enochian Biosciences (ENOB) United States $0.293B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.292B 0.00
BioDelivery Sciences (BDSI) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Merus (MRUS) Netherlands $0.280B 0.00
Urovant Sciences (UROV) United States $0.274B 0.00
MeiraGTx Holdings (MGTX) United States $0.273B 0.00
Sorrento Therapeutics (SRNE) United States $0.263B 0.00
Gamida Cell (GMDA) Israel $0.259B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.258B 0.00
Kadmon Holdings (KDMN) United States $0.257B 0.00
Axsome Therapeutics (AXSM) United States $0.254B 0.00
Intec Pharma (NTEC) Israel $0.245B 0.00
Verastem (VSTM) United States $0.243B 0.00
Celcuity (CELC) United States $0.241B 0.00
ResTORbio (TORC) United States $0.233B 0.00
Syros Pharmaceuticals (SYRS) United States $0.233B 0.00
Seres Therapeutics (MCRB) United States $0.231B 0.00
Magenta Therapeutics (MGTA) United States $0.229B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
MannKind (MNKD) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
Strongbridge Biopharma (SBBP) United States $0.219B 0.00
Celyad SA (CYAD) Belgium $0.219B 0.00
Liquidia Technologies (LQDA) United States $0.217B 0.00
PSivida (EYPT) United States $0.215B 0.00
Aduro Biotech (ADRO) United States $0.215B 0.00
Kamada (KMDA) Israel $0.212B 19.52
Cerecor (CERC) United States $0.211B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.210B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.209B 0.00
XBiotech (XBIT) United States $0.208B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.202B 0.00
Equillium (EQ) United States $0.200B 0.00
Adverum Biotechnologies (ADVM) United States $0.197B 0.00
Athersys (ATHX) United States $0.197B 0.00
Arbutus Biopharma (ABUS) Canada $0.196B 0.00
CorMedix Inc (CRMD) United States $0.196B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.196B 0.00
Protagonist Therapeutics (PTGX) United States $0.193B 0.00
Aptinyx (APTX) United States $0.192B 0.00
Geron (GERN) United States $0.190B 0.00
Kala Pharmaceuticals (KALA) United States $0.187B 0.00
Compugen (CGEN) Israel $0.183B 0.00
Synlogic (SYBX) United States $0.180B 0.00
Enzo Biochem (ENZ) United States $0.177B 0.00
ChromaDex (CDXC) United States $0.176B 0.00
LogicBio Therapeutics (LOGC) United States $0.176B 0.00
TOCAGEN INC (TOCA) United States $0.174B 0.00
Allena Pharmaceuticals (ALNA) United States $0.173B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.172B 0.00
VBI Vaccines (VBIV) United States $0.164B 0.00
Constellation Pharmaceuticals (CNST) United States $0.164B 0.00
ADMA Biologics Inc (ADMA) United States $0.158B 0.00
Cohbar (CWBR) United States $0.153B 0.00
Motif Bio Plc (MTFB) United States $0.148B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.144B 0.00
Palatin Technologies (PTN) United States $0.144B 17.75
Erytech Pharma SA Sponsored ADR (ERYP) France $0.143B 0.00
Spero Therapeutics (SPRO) United States $0.143B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.136B 0.00
Menlo Therapeutics (MNLO) United States $0.133B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.131B 0.00
OvaScience (MLND) United States $0.130B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Pluristem Therapeutics (PSTI) Israel $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.121B 0.00
BioTime (BTX) United States $0.119B 0.00
Axovant Sciences (AXON) United Kingdom $0.117B 0.00
Cue Biopharma (CUE) United States $0.115B 0.00
Organovo Holdings (ONVO) United States $0.114B 0.00
Pfenex (PFNX) United States $0.114B 0.00
VTv Therapeutics (VTVT) United States $0.111B 0.00
XOMA (XOMA) United States $0.110B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.110B 0.00
Checkpoint Therapeutics (CKPT) United States $0.109B 0.00
ETON PHARMACEUT (ETON) United States $0.107B 0.00
Proteostasis Therapeutics (PTI) United States $0.107B 0.00
NantKwest (NK) United States $0.102B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.101B 0.00
Neothetics (EVFM) United States $0.099B 0.00
Cocrystal Pharma (COCP) United States $0.097B 108.33
Catalyst Biosciences (CBIO) United States $0.096B 0.00
Signal Genetics (MGEN) United States $0.093B 0.00
Chiasma (CHMA) United States $0.092B 0.00
BioXcel Therapeutics (BTAI) United States $0.090B 0.00
PHASEBIO PHARMA (PHAS) United States $0.089B 0.00
VolitionRX (VNRX) Singapore $0.089B 0.00
OVID THERAPEUTC (OVID) United States $0.086B 0.00
ITUS (ANIX) United States $0.085B 0.00
Mersana Therapeutics (MRSN) United States $0.083B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.082B 0.00
Mustang Bio (MBIO) United States $0.082B 0.00
Cidara Therapeutics (CDTX) United States $0.082B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.081B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Aptose Biosciences (APTO) Canada $0.081B 0.00
Anavex Life Sciences (AVXL) United States $0.080B 0.00
Cel-Sci (CVM) United States $0.078B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
Idera Pharmaceuticals (IDRA) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
ScPharmaceuticals (SCPH) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
AEterna Zentaris (AEZS) United States $0.059B 11.22
Fortress Biotech (FBIO) United States $0.059B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
Oncobiologics (OTLK) United States $0.058B 0.00
Monster Digital (INNT) United States $0.058B 0.00
Eleven Biotherapeutics (SESN) United States $0.057B 0.00
Evogene (EVGN) Israel $0.056B 0.00
Celldex Therapeutics (CLDX) United States $0.056B 0.00
Ophthotech (OPHT) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 0.00
Alcobra (ARCT) United States $0.053B 0.00
Bellerophon Therapeutics (BLPH) United States $0.052B 0.00
NewLink Genetics (NLNK) United States $0.051B 0.00
Proteon Therapeutics (PRTO) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.046B 0.00
Arsanis (ASNS) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.044B 0.00
OncoSec Medical (ONCS) United States $0.044B 0.00
Trevena (TRVN) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Celsion (CLSN) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Selecta Biosciences (SELB) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
AZURRX BIOPHARM (AZRX) United States $0.042B 0.00
Versartis (ARAV) United States $0.040B 3.54
Leap Therapeutics (LPTX) United States $0.040B 0.00
Entera Bio (ENTX) Israel $0.040B 0.00
Asterias Biotherapeutics (AST) United States $0.040B 0.00
Adial Pharmaceuticals (ADIL) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
Clearside Biomedical (CLSD) United States $0.036B 0.00
Curis (CRIS) United States $0.035B 0.00
Sophiris Bio (SPHS) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
TRACON Pharmaceuticals (TCON) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.029B 4.69
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
BioPharmX (BPMX) United States $0.024B 0.00
GTx (GTXI) United States $0.022B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Vical (VICL) United States $0.020B 0.00
CytRx (CYTR) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
Benitec Biopharma (BNTC) Australia $0.016B 0.00
Cellect Biotechnology (APOP) Israel $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Novogen (KZIA) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.58
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Pulmatrix (PULM) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.007B 0.00
Neuralstem (CUR) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00